Clinical Trials Browser

Hydatidiform Mole × Leucovorin × Clear all

NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Phase 3 Completed

57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole